Navigation Links
LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
Date:3/21/2012

CENTENNIAL, Colo., March 21, 2012 /PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, this month launches a group of new laboratory tests suitable for screening complex biologic products. These new offerings will allow the company to provide innovative solutions with faster turnaround times to meet the needs of existing and future clients.

"The medical and scientific industries are creating products that do not readily conform to the legacy compendial assays. As such, LABS is committed to taking a leadership role to provide alternative solutions for these complex biologic products, which often require faster test results from smaller sample volumes," said Chad Ronholdt, Vice President Strategic Development of LABS, Inc.

LABS this month launches five new tests:

  • Novartis Procleix Tigris System: a new, fully automated Nucleic Acid Testing (NAT) platform for infectious disease screening. NAT is the gold standard to detect HIV-1, Hepatitis B and Hepatitis C viruses for the purposes of human organ, eye, cell and tissue donor eligibility screening.  LABS is the only complex biologic testing facility in North America to offer this new, superior platform. The automated platform minimizes operator-induced variability and allows LABS to capitalize on efficiencies that the older, manual donor eligibility methods cannot offer.
  • MYcoSEQ™ Mycoplasma Real-Time Polymerase Chain Reaction (RT-PCR) Detection Assay: a robust, reliable and efficient method for detecting more than 90 species of Mycoplasma contamination within seven days. This new assay, independently validated by LABS, is ideal for the evaluation of upstream and mid-stream processing samples during the manufacturing of human biologic and cellular-based products and/or r
    '/>"/>

SOURCE LABS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. The Rett Syndrome Research Trust launches operations
2. LIAI launches new division to look at novel approaches to heart disease and inflammation
3. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
4. TheVisualMD.com launches new animated 3-D views of human body in action
5. International Council for Science launches major research program on natural disasters
6. ICSU launches new program to understand the human impact on Earths life-support systems
7. North American environmental commission launches trinational vaquita conservation plan
8. OSAs ISP launches with research on breathing disorders and congenital heart defects
9. Futronic Launches FS22 Fingerprint Access Control Device
10. Springer launches Food Security
11. From sheet metal elements to host cells: DFG launches 10 new collaborative research centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
(Date:11/6/2014)... deaths occur because of metastasis, yet progress in ... slow. , "It,s been particularly challenging to design ... research fellow in systems biology at Harvard Medical ... until after they,ve already metastasized." , Gujral and ... should help researchers better understand how metastasis begins. ...
(Date:11/5/2014)... – Kelly Redmond has dedicated his career to ... to a general audience. , As deputy director ... Center at Nevada,s Desert Research Institute, Redmond has ... management, application and dissemination of climate data to ... Fall Meeting in San Francisco on December 15-19, ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... scientists at UCLA showed for the first time that ... into electrically active motor neurons, a discovery that may ... the motor neurons derived from the iPS cells appeared ... derived from human embryonic stem cells, although further testing ...
... WASHINGTONResearchers are exploring extreme conditions for life in a ... 20 meters (66 feet) below the surface of Lake ... peculiar geological formationssinkholes made by water dissolving parts of ... typical of the huge freshwater lake are rarely to ...
... , McGill University chemistry professor Chao-Jun (C.J.) Li is ... chemistry, an entirely new approach to the science which eschews ... substances like water and new ways of making molecules. ... significant, but following the road less travelled is also paying ...
Cached Biology News:UCLA stem cells scientists make electrically active motor neurons from iPS cells 2Great Lake's sinkholes host exotic ecosystems 2Peptides-on-demand: McGill researcher's radical new green chemistry makes the impossible possible 2
(Date:11/23/2014)... Apiscent Labs, a privately held ... ingredients to the global pharmaceutical and flavor & ... website, Apiscent.com. , The Apiscent.com homepage welcomes visitors ... easy navigation, rotating images and content focused on ... , The company’s work in Pharmaceutical ...
(Date:11/22/2014)... London (PRWEB) November 21, 2014 Two new ... explore what comes next for ALS research and how the ... , After the Ice Bucket Challenge: Where Does the ALS ... Tuesday, 2 December 2014, Time: 1:30pm ET, ... Join expert speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of ...
(Date:11/22/2014)... 21, 2014 During his lifetime Richard ... need to surround himself with great people and take ... his friends often marveled at his extraordinarily courageous attitude ... life and -- even with his death impending—that’s how ... disease that would ultimately take his life. , Carrying ...
(Date:11/22/2014)... 21, 2014 Prominent academics, leaders ... gather on December 3rd at Genetic Rx, a ... GeneticRx will take place at the Joseph B. ... will discuss the present and future of genetic ... and gene editing—as well as the treatment of ...
Breaking Biology Technology:DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... McCormick School of Engineering and Applied Science at Northwestern ... of probe used in atomic force microscopy (AFM), which ... Using diamond, researchers made a much more durable ... are typically used in AFM to gather information from ...
... SEATTLE, Nov. 11 Dendreon Corporation (Nasdaq: DNDN ) ... Revenue for the third quarter of 2009 was $25,000 compared ... for the nine months ended September 30, 2009 was $80,000 ... 2008. , Dendreon,s total operating expenses for the third ...
... HAIKOU CITY, China, Nov. 11 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, ... specialty pharmaceutical products in China, today announced financial,results for the ... Third Quarter 2009 Financial Highlights, -- ... the, third quarter of ...
Cached Biology Technology:New nanocrystalline diamond probes overcome wear 2Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 2Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 3Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 4Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 5Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 6China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 2China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 3China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 4China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 5China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 6China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 7China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 8China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 9
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
... Antigen peptide transporter ... TAP2) (Peptide transporter PSF2) ... (PSF-2) (Peptide transporter involved ... [Source:Uniprot/SWISSPROT;Acc:Q03519] ...
Goat polyclonal to JIK ( Abpromise for all tested applications). Antigen: Synthetic peptide: HKKDHVFIRDEAGHGD, corresponding to amino acids 396-411 of Human JIK. Entrez Gene ID: 51347 Swi...
Biology Products: